EugeneRecruiter Since 2001
the smart solution for Eugene jobs

Senior Medical Director, Clinical Development - Melanoma Studies

Company: Karyopharm Therapeutics
Location: Remote
Posted on: June 10, 2021

Job Description:


The Senior Medical Director will serve as the primary medical lead for Karyopharm clinical trials with cross-functional study teams on clinical trial strategy, design and execution. Along with this, the Medical Director will serve as the primary Medical Monitor responsible for monitoring the safety of enrolled subjects on assigned trials. This role will specifically focus on strategy and development of Karyopharm's Melanoma program along with other solid tumor indications.

  • Participates in the development of Study Protocols, Investigator's Brochures, Clinical Development Plans and other key study documents in conjunction with other line functions and with minimal guidance.
  • Serves on cross-functional teams for assigned trials, working with other team members to achieve efficient, high-quality study execution.
  • Participates in the preparation of regulatory documents in support of regulatory submissions, including clinical section of IND's and CTA's, IND safety reports and annual reports for assigned trials, responses to regulatory authorities and Ethics Committees/IRBs, and other documents as appropriate.
  • Provides scientific and clinical input to study-related documents and analysis plans including Informed consent forms (ICF), clinical research forms (CRF), statistical analysis plans (SAP), clinical pharmacology analysis plans (CPAP), and clinical study reports (CSR).
  • Acts as liaison between Clinical Development and other internal groups at Karyopharm (e.g., Regulatory Affairs, Clinical Operations, Clinical Data Management) for assigned studies.
  • Develop and execute life-cycle management plan, lead data generation activities such as medical affairs studies to unmet medical needs and data gaps
  • Support Medical Affairs: Working with field medical, Scientific Communication and Publication, Medical Information and Communication teams and provide support including reactive material development to address external stakeholder questions
  • Help identify and effectively interact with thought leaders to engage in scientific and medical exchange as well as understand unmet medical needs and data gaps
  • Support IST Program
  • Partner with pharmacovigilance to assess the safety profile of compounds
  • Maintain a high level of clinical and scientific expertise in the disease area(s) by reviewing the literature, attending medical/scientific meetings, and through personal interchanges with consultants, thought leaders, investigators and internal stakeholder.
  • Author manuscripts and collaborate with cross-functional colleagues and thought leaders to meet publication plan objectives
  • Maintain ethical standards of the highest level and have the knowledge and ability to comply with all relevant ethical, regulatory, and legal standards
  • May participate in or lead clinical development contributions to due diligence or other business development activity
  • As required by program needs, contribute in partnership with Discovery colleagues to the design and implementation of translational strategies
  • Has overall responsibility for leading clinical study teams, monitoring overall study integrity, and review, interpretation, and communication of accumulating data pertaining to safety and efficacy of the molecule
  • Present at scientific, medical and regulatory meetings globally
  • Develop and maintain relationships with academic investigators, pharmaceutical partners/sponsors, KOL's, and patient advocacy groups
  • Contribute to activities in support of the company's planned NDA submissions. Author clinical sections for INDs, NDAs, and other related documents


  • MD, DO or equivalent ex-US medical degree.
  • 1-2 years of experience developing strategy and execution of Melanoma studies along with experience with other solid tumor indications.
  • 5-10 years clinical trial experience in an academic or industrial setting, with experience in analysis of research data and publications; working knowledge of biostatistics and pharmacokinetics; working knowledge of GCP, scientific and clinical research methods and clinical study design, regulatory requirements for clinical studies;
  • At least 3 years as an attending physician in oncology, hematology, internal medicine, or relevant medical specialty area;
  • Cancer research experience;
  • Pharmaceutical/Biotech industry experience, including time managing clinical trials and/or clinical development program(s) mandatory.
  • Excellent oral and written communication skills
  • Ability to work collaboratively in a fast-paced, team-based matrix environment and to function independently as appropriate


Karyopharm Therapeutics Inc. (NASDAQ: KPTI) is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of first-in-class drugs directed against nuclear export for the treatment of cancer and other diseases. Karyopharm's Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1). Karyopharm's lead compound, XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. NEXPOVIO (selinexor) has also been granted conditional marketing authorization in combination with dexamethasone for adult patients with heavily pretreated multiple myeloma by the European Commission. In addition to single-agent and combination activity against a variety of human cancers, SINE compounds have also shown biological activity in models of neurodegeneration, inflammation, autoimmune disease, certain viruses and wound-healing. Karyopharm has several investigational programs in clinical or preclinical development. For more information, please visit

Karyopharm Therapeutics Inc. (the "Company") is an equal opportunity employer. All qualified applicants will be considered without regard to age, race, color, sex, religion/creed, national origin, marital status, ancestry, citizenship, military, reservist or veteran status, pregnancy, sexual orientation or preference, gender identity, gender expression, physical or mental disability, genetic predisposition or carrier status, or any other category protected under applicable federal, state or local law. Consistent with its obligations under applicable law, the Company will make reasonable accommodations for qualified individuals with disabilities. If you require an accommodation in the application process, please contact a member of the Company's Human Resources department.

Keywords: Karyopharm Therapeutics, Eugene , Senior Medical Director, Clinical Development - Melanoma Studies, Other , Remote, Oregon

Click here to apply!

Didn't find what you're looking for? Search again!

I'm looking for
in category

Log In or Create An Account

Get the latest Oregon jobs by following @recnetOR on Twitter!

Eugene RSS job feeds